Spritam

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 43485-101
  • Package NDC 43485-101-03
  • Package NDC 43485-101-60
  • Application number NDA207958
  • SPL ID 890ef534-7363-4f2b-b125-8f62e2eb26d0
  • SPL set ID be651c31-383f-11e4-916c-0800200c9a66
  • UNII 44YRR34555
  • RxCUI 1736037
  • RxCUI 1736044
  • RxCUI 1736045
  • RxCUI 1736047
  • RxCUI 1736048
  • RxCUI 1736050
  • RxCUI 1736051
  • RxCUI 1736053

What the source publishes

Labeler
Aprecia Pharmaceuticals, LLC
Active ingredients
levetiracetam
Form
TABLET, FOR SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:43485-101_890ef534-7363-4f2b-b125-8f62e2eb26d0
{
  "name": "Spritam",
  "splId": "890ef534-7363-4f2b-b125-8f62e2eb26d0",
  "labels": [
    {
      "setId": "be651c31-383f-11e4-916c-0800200c9a66",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be651c31-383f-11e4-916c-0800200c9a66",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be651c31-383f-11e4-916c-0800200c9a66"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Aprecia Pharmaceuticals, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "6 BLISTER PACK in 1 CARTON (43485-101-03)  / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (43485-101-01)",
      "package_ndc": "43485-101-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260131"
    },
    {
      "sample": false,
      "description": "60 BLISTER PACK in 1 CARTON (43485-101-60)  / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (43485-101-01)",
      "package_ndc": "43485-101-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160205"
    }
  ],
  "productId": "43485-101_890ef534-7363-4f2b-b125-8f62e2eb26d0",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FOR SUSPENSION",
  "productNdc": "43485-101",
  "deaSchedule": null,
  "genericName": "levetiracetam",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LEVETIRACETAM",
      "strength": "250 mg/1"
    }
  ],
  "applicationNumber": "NDA207958",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160205",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486"
    ],
    "unii": [
      "44YRR34555"
    ],
    "rxcui": [
      "1736037",
      "1736044",
      "1736045",
      "1736047",
      "1736048",
      "1736050",
      "1736051",
      "1736053"
    ],
    "spl_set_id": [
      "be651c31-383f-11e4-916c-0800200c9a66"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "manufacturer_name": [
      "Aprecia Pharmaceuticals, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:43485-101_890ef534-7363-4f2b-b125-8f62e2eb26d0"